Godrej Agrovet Limited · NSE:GODREJAGRO
Godrej Agrovet — Q2 FY2021 Earnings Presentation
19 slides from Godrej Agrovet's earnings presentation, Nov 4, 2020
Slide 1: Exchange filing cover letter: Presentation to Investors & Analysts
Date: November 4, 2020 To, To, BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort Exchange Plaza, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai-400 051 Ref.: BSE Scrip Code No. “540743” Ref.: “GODREJAGRO” Sub: Presentation to Investors & Analysts D
Slide 2: Q2FY21 & H1FY21 Performance Update
GODREJ AGROVET LIMITED Q2FY21 & H1FY21 PERFORMANCE UPDATE November 04, 2020
Slide 3: GAVL Performance Highlights
GAVL PERFORMANCE HIGHLIGHTS 2 I Godrej Agrovet
Slide 4: Q2FY21 Financials – Key Highlights
Q2FY21 FINANCIALS – KEY HIGHLIGHTS Particulars Standalone Consolidated (Rs crore, unless stated) Q2FY21 Q2FY20 Growth Q2FY21 Q2FY20 Growth Total Income 1,255.9 1,391.9 (9.8%) 1,732.2 1,862.5 (7.0%) Earnings before interest, tax and 135.9 120.1 13.2% 181.5 131.1 38.5% Depreciation (EBITDA) EBITDA Mar
Slide 5: H1FY21 Financials – Key Highlights
H1FY21 FINANCIALS – KEY HIGHLIGHTS Particulars Standalone Consolidated (Rs crore, unless stated) H1FY21 H1FY20 Growth H1FY21 H1FY20 Growth Total Income 2,419.5 2,653.5 (8.8%) 3,294.6 3,575.2 (7.8%) Earnings before interest, tax 278.2 246.0 13.1% 355.7 283.2 25.6% and Depreciation (EBITDA) EBITDA Mar
Slide 6: H1FY21 Segment-wise Revenue and PBIT
H1FY21 SEGMENT-WISE REVENUE AND PBIT Segment Revenue Mix(1) Profit before interest and taxes (2) Poultry & Poultry & processed processed food food Others 9.0% Dairy 0.6% 6.6% 2.2% Animal Feed 28.9% Dairy 14.4% Animal Feed 43.9% Crop Crop Protection Protection 19.0% 47.9% Oil Palm Plantation 14.4% Oi
Slide 7: Consolidated Balance Sheet – Key Highlights
CONSOLIDATED BALANCE SHEET – KEY HIGHLIGHTS Particulars September 30, 2020 March 31, 2020 Net Working Capital Rs. Crore 519.0 493.3 (Ex-cash and equivalents) Net Working Capital days Days 29 26 Total Debt Rs. Crore 449.6 630.3 Net Debt Rs. Crore 402.1 581.6 Equity (ex- minority interest) Rs. Crore 1
Slide 8: Ensuring Operational Efficiency and Financial Prudence in Current Times
ENSURING OPERATIONAL EFFICIENCY AND FINANCIAL PRUDENCE IN CURRENT TIMES • Early signs of economic recovery are visible Economic indicators are highlighting that the worst is behind Demand in rural India is recovering faster than urban centres Good monsoon, higher Kharif acreage and high reserv
Slide 9: Segment-wise Performance Update
SEGMENT-WISE PERFORMANCE UPDATE 8 I Godrej Agrovet
Slide 10: Animal Feed
ANIMAL FEED Leading compound feed play across Cattle (Milk), Broiler, Layer, Fish and Shrimp feed in India Particulars Q2FY21 Q2FY20 Growth H1FY21 H1FY20 Growth Sales Volume (tons) 2,79,906 3,32,301 (15.8%) 5,47,655 6,56,336 (16.6%) Segment Revenue (Cr) 762.3 938.7 (18.8%) 1,510.3 1,823.7 (17.2%) Se
Slide 11: Oil Palm Business
OIL PALM BUSINESS Largest domestic producer of Crude Palm oil and Palm Kernel Oil Particulars Q2FY21 Q2FY20 Growth H1FY21 H1FY20 Growth Segment Revenue (Cr) 293.2 236.6 23.9% 450.5 382.0 17.9% Segment Result (Cr) 41.4 28.8 44.0% 47.9 41.4 15.6% Segment Margin (%) 14.1% 12.2% 10.6% 10.8% • Segment re
Slide 12: Crop Protection Business
CROP PROTECTION BUSINESS Agrochemical products produced cater to the entire crop lifecycles Particulars Q2FY21 Q2FY20 Growth H1FY21 H1FY20 Growth Segment Revenue (Cr) 176.3 200.2 (11.9%) 384.5 409.5 (6.1%) Segment Result (Cr) 49.5 55.0 (10.0%) 109.9 129.5 (15.1%) Segment Margin (%) 28.1% 27.5% 28.6%
Slide 13: Astec Lifesciences
ASTEC LIFESCIENCES Manufactures a wide range of agrochemical active ingredients and pharmaceutical intermediates Particulars Q2FY21 Q2FY20 Growth H1FY21 H1FY20 Growth Revenues (Cr.) 155.0 140.2 10.5% 266.9 217.2 22.9% EBITDA (Cr.) 31.4 17.1 83.5% 60.9 24.4 149.4% EBITDA Margin (%) 20.2% 12.2% 22.8%
Slide 14: Creamline Dairy
CREAMLINE DAIRY Particulars Q2FY21 Q2FY20 Growth H1FY21 H1FY20 Growth Revenue (Cr.) 259.0 306.3 (15.3%) 495.4 626.7 (20.7%) EBITDA (Cr.) 11.2 9.1 22.6% 21.5 22.9 (6.4%) EBITDA Margin (%) 4.3% 3.0% 4.3% 3.7% • Low out-of-home consumption and subdued demand from HoReCa segment has adversely impacted t
Slide 15: Godrej Tyson Foods Limited and ACI Godrej Agrovet joint venture
GODREJ TYSON FOODS LIMITED Particulars Q2FY21 Q2FY20 Growth H1FY21 H1FY20 Growth Revenue (Cr) 143.1 107.6 33.0% 308.5 243.4 26.8% EBITDA (Cr) 9.0 (11.1) NA 30.5 (4.7) NA EBITDA margin % 6.3% (10.3%) 9.9% (1.9%) • In Yummiez segment, our products continue to receive excellent customer response across
Slide 16: GAVL Shareholding Pattern
GAVL SHAREHOLDING PATTERN Major Investors Shareholding pattern as on September 30, 2020 • Temasek Others , 9.5% • Aberdeen DII, 5.1% • Kotak Mutual Fund • LIC India • DSP FII, 15.4% • Vanguard • ICICI MF Promoters, 70.1% • Bajaj Holdings • Tata AIG • JP Morgan 15 I Godrej Agrovet
Slide 17: Contact Us
CONTACT US To know more, visit us at: www.godrejagrovet.com S Varadaraj Chhavi Agarwal Email: s.varadaraj@godrejagrovet.com Email: chhavi.agarwal@godrejagrovet.com gavlinvestors@godrejagrovet.com gavlinvestors@godrejagrovet.com 16 I Godrej Agrovet
Slide 18: Disclaimer
DISCLAIMER Some of the statements in this communication may be forward looking statements within the meaning of applicable laws and regulations. Actual results might differ substantially from those expressed or implied. Important developments that could affect the Company’s operations include change
Slide 19: Thank You for Your Time and Consideration
THANK YOU FOR YOUR TIME AND CONSIDERATION 18 I Godrej Agrovet